Literature DB >> 8418890

Reversible and irreversible inactivation of preformed pulmonary surfactant surface films by changes in subphase constituents.

J D Amirkhanian1, H W Taeusch.   

Abstract

Several mechanisms for surfactant inactivation have been reported. In this study, we have measured the reversibility of surfactant inactivation caused by various lipid or protein constituents of plasma or by pH changes. A surfactant of bovine origin was studied in a pulsating surfactometer either when surfactants were premixed with different serum constituents (inactivators) or when inactivators were introduced into subphase fluid surrounding surfactant films formed at an air-liquid interface. Subphase exchanges with sodium bicarbonate or sodium borate raised pH and raised minimal surface tensions either when premixed with surfactant or when introduced with saline subphase beneath a preformed surfactant surface film. The pH effects on surfactant film function were reversible for sodium bicarbonate but not for sodium borate when the subphase with bicarbonate or borate was replaced with saline. Lipids (platelet-activating factor or lysophosphatidylcholine) had non-reversible effects on preformed films. Proteins (fibrinogen or C reactive protein) had reversible effects at low concentrations, but reversibility was less evident at high concentrations. Effects with whole serum were non-reversible at low protein concentrations (0.5 mg/ml). These results add evidence that surfactant inactivation can be caused by multiple mechanisms, both reversible and irreversible.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418890     DOI: 10.1016/0005-2760(93)90143-w

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimental.

Authors:  H William Taeusch; Jorge Bernardino de la Serna; Jesus Perez-Gil; Coralie Alonso; Joseph A Zasadzinski
Journal:  Biophys J       Date:  2005-05-27       Impact factor: 4.033

2.  Effects of cationic liposome-DNA complexes on pulmonary surfactant function in vitro and in vivo.

Authors:  P Boncuk; M Kaser; Y Yu; H W Taeusch
Journal:  Lipids       Date:  1997-03       Impact factor: 1.880

3.  Reduction of the surface-tension-lowering ability of surfactant after exposure to hypochlorous acid.

Authors:  T A Merritt; J D Amirkhanian; H Helbock; B Halliwell; C E Cross
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

4.  Inhibition of pulmonary surfactant biophysical activity by cationic polyamino acids.

Authors:  P M Bummer; S Aziz; M N Gillespie
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

5.  Phase transitions in films of lung surfactant at the air-water interface.

Authors:  K Nag; J Perez-Gil; M L Ruano; L A Worthman; J Stewart; C Casals; K M Keough
Journal:  Biophys J       Date:  1998-06       Impact factor: 4.033

6.  The influence of pH on surface properties of lung surfactants.

Authors:  J D Amirkhanian; T A Merritt
Journal:  Lung       Date:  1995       Impact factor: 2.584

7.  Antigen-induced generation of lyso-phospholipids in human airways.

Authors:  F H Chilton; F J Averill; W C Hubbard; A N Fonteh; M Triggiani; M C Liu
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.